250 related articles for article (PubMed ID: 15517903)
1. Novel recurrent structural chromosomal aberrations in primary bladder cancer.
Panani AD; Ferti AD; Raptis SA; Roussos C
Anticancer Res; 2004; 24(5A):2967-74. PubMed ID: 15517903
[TBL] [Abstract][Full Text] [Related]
2. Non-random structural chromosomal changes in ovarian cancer: i(5p) a novel recurrent abnormality.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(1):130-5. PubMed ID: 15927360
[TBL] [Abstract][Full Text] [Related]
3. Non-random structural chromosomal changes in primary gastric cancer.
Panani AD; Roussos C
Cancer Lett; 2005 Jul; 225(2):291-5. PubMed ID: 15978333
[TBL] [Abstract][Full Text] [Related]
4. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder.
Gibas Z; Prout GR; Connolly JG; Pontes JE; Sandberg AA
Cancer Res; 1984 Mar; 44(3):1257-64. PubMed ID: 6692407
[TBL] [Abstract][Full Text] [Related]
5. Toward the validation of aneusomy detection by fluorescence in situ hybridization in bladder cancer: comparative analysis with cytology, cytogenetics, and clinical features predicts recurrence and defines clinical testing limitations.
Zhang FF; Arber DA; Wilson TG; Kawachi MH; Slovak ML
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2317-28. PubMed ID: 9815630
[TBL] [Abstract][Full Text] [Related]
6. Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma.
Höglund M; Säll T; Heim S; Mitelman F; Mandahl N; Fadl-Elmula I
Cancer Res; 2001 Nov; 61(22):8241-6. PubMed ID: 11719456
[TBL] [Abstract][Full Text] [Related]
7. Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization.
Stamouli MI; Panani AD; Ferti AD; Petraki C; Oliver RT; Raptis SA; Young BD
Cancer Genet Cytogenet; 2004 Mar; 149(2):107-13. PubMed ID: 15036885
[TBL] [Abstract][Full Text] [Related]
8. [Chromosomal analysis of primary superficial tumors of the bladder].
Martorana G; Giberti C; de Ferrari M; Ottaggio L; Giuliani L
J Urol (Paris); 1983; 89(7):489-92. PubMed ID: 6655279
[TBL] [Abstract][Full Text] [Related]
9. C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
Leonardo C; Merola R; Orlandi G; Leonardo F; Rondoni M; De Nunzio C
J Exp Clin Cancer Res; 2005 Dec; 24(4):633-8. PubMed ID: 16471327
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis.
Khaled HM; Aly MS; Mokhtar N
Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858
[TBL] [Abstract][Full Text] [Related]
11. Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients.
Panani AD; Babanaraki A; Malianga E; Roussos Ch
Anticancer Res; 2004; 24(6):3857-61. PubMed ID: 15736422
[TBL] [Abstract][Full Text] [Related]
12. Preferential involvement of chromosome 11 as add(11)(p15) in ovarian cancer: is it a common cytogenetic abnormality in cancer?
Panani AD
Cancer Lett; 2007 Dec; 258(2):262-7. PubMed ID: 17945413
[TBL] [Abstract][Full Text] [Related]
13. Assessment by M-FISH of karyotypic complexity and cytogenetic evolution in bladder cancer in vitro.
Ratliff TL
J Urol; 2005 Nov; 174(5):2065. PubMed ID: 16217396
[No Abstract] [Full Text] [Related]
14. Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analyses.
Sáez B; Martín-Subero JI; Largo C; Martín MC; Odero MD; Prosper F; Siebert R; Calasanz MJ; Cigudosa JC
Cancer Genet Cytogenet; 2006 Sep; 169(2):143-9. PubMed ID: 16938572
[TBL] [Abstract][Full Text] [Related]
15. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
16. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis.
Fadl-Elmula I; Kytölä S; Pan Y; Lui WO; Derienzo G; Forsberg L; Mandahl N; Gorunova L; Bergerheim US; Heim S; Larsson C
Int J Cancer; 2001 Jun; 92(6):824-31. PubMed ID: 11351302
[TBL] [Abstract][Full Text] [Related]
17. Identification of genetic alterations in upper urinary tract urothelial carcinoma in end-stage renal disease patients.
Wu CF; Pang ST; Shee JJ; Chang PL; Chuang CK; Chen CS; Liao SK; Weng WH
Genes Chromosomes Cancer; 2010 Oct; 49(10):928-34. PubMed ID: 20629096
[TBL] [Abstract][Full Text] [Related]
18. Detection of chromosomal alterations in bladder transitional cell carcinomas from Northern China by comparative genomic hybridization.
Qin SL; Chen XJ; Xu X; Shou JZ; Bi XG; Ji L; Han YL; Cai Y; Wei F; Ma JH; Wu M; Zhan QM; Wang MR
Cancer Lett; 2006 Jul; 238(2):230-9. PubMed ID: 16125302
[TBL] [Abstract][Full Text] [Related]
19. Molecular cytogenetic characterization and diagnostics of bladder cancer.
Houskova L; Zemanova Z; Babjuk M; Melichercikova J; Pesl M; Michalova K
Neoplasma; 2007; 54(6):511-6. PubMed ID: 17949235
[TBL] [Abstract][Full Text] [Related]
20. Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
Panani AD; Roussos C
Anticancer Res; 2006; 26(1A):319-23. PubMed ID: 16475713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
